GlassScriptPhysician profile
Fred M Itveldt
NPI 1619393204
$2,705.81
in general payments reported to CMS, 2019-2025
16 companies · $533 in 2025
The $533 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $320 · 2022: $556 · 2023: $284 · 2024: $1,012 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,643 · Consulting Fee: $115 · Education: $71.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,642.74 |
| Consulting Fee | $115.00 |
| Education | $71.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $732.06 | 2021-2025 | Spravato, Invega Sustenna, Invega Trinza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $383.80 | 2021-2024 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $268.49 | 2023-2025 | Austedo Xr, Uzedy, Austedo Xr |
| Abbvie INC. | $239.48 | 2022-2024 | |
| Otsuka America Pharmaceutical, INC. | $182.17 | 2021-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| E.R. Squibb & Sons, L.L.C. | $163.04 | 2024-2025 | Cobenfy |
| Sunovion Pharmaceuticals INC. | $142.38 | 2021-2022 | |
| Braeburn INC. | $137.32 | 2023-2024 | Brixadi |
| Janssen Scientific Affairs, LLC | $115.00 | 2024 | Spravato |
| Axsome Therapeutics, INC. | $92.52 | 2024-2025 | Auvelity |
| Indivior INC. | $83.46 | 2021-2022 | |
| Corium, LLC | $49.14 | 2023 | Azstarys |
| Neurocrine Biosciences, INC. | $46.11 | 2024-2025 | Ingrezza |
| Alkermes, INC. | $34.80 | 2022-2023 | Aristada, Lybalvi |
| Lundbeck LLC | $23.85 | 2025 | Rexulti |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $12.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Itveldt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.